Growth factor therapy and lymph node graft for lymphedema

Journal of Surgical Research

Volumn 196, Issue 1, 2015, Pages 200-207

  Tervala, Tomi V ^a   Hartiala, Pauliina ^b   Tammela, Tuomas ^c   Visuri, Mikko T ^b   Ylä Herttuala, Seppo ^d   Alitalo, Kari ^c   Saarikko, Anne M ^b,e  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d UNIVERSITY OF EASTERN FINLAND   (Finland)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Lymph node transfer; Lymphedema; Vascular endothelial growth factor

Indexed keywords

CD31 ANTIGEN; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN C; VASCULOTROPIN C156S; VASCULOTROPIN D; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AXILLARY LYMPH NODE; CONTROLLED STUDY; DRUG EFFICACY; INFLAMMATORY CELL; LYMPH NODE; LYMPH NODE GRAFT; LYMPH VESSEL; LYMPHANGIOGENESIS; LYMPHEDEMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; THERAPY; THERAPY EFFECT; TISSUE GRAFT; ANIMAL; LYMPHOGRAPHY; PATHOPHYSIOLOGY; PHYSIOLOGY; TRANSPLANTATION;

ANIMALS; LYMPH NODES; LYMPHANGIOGENESIS; LYMPHEDEMA; LYMPHOGRAPHY; MICE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3;

EID: 84929293275     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2015.02.031     Document Type: Article

References (39)

1. M.H. Witte, and C.L. Witte Lymphatics and blood vessels, lymphangiogenesis and hemangiogenesis: from cell biology to clinical medicine Lymphology 20 1987 257
2. E.F. Tewalt, J.N. Cohen, S.J. Rouhani, and V.H. Engelhard Lymphatic endothelial cells - key players in regulation of tolerance and immunity Front Immunol 3 2012 305
3. K. Alitalo, T. Tammela, and T.V. Petrova Lymphangiogenesis in development and human disease Nature 438 2005 946
4. C. Becker, J. Assouad, M. Riquet, and G. Hidden Postmastectomy lymphedema: long-term results following microsurgical lymph node transplantation Ann Surg 243 2006 313
5. K.M. Honkonen, M.T. Visuri, and T.V. Tervala Lymph node transfer and perinodal lymphatic growth factor treatment for lymphedema Ann Surg 257 2013 961
6. T. Tammela, A. Saaristo, and T. Holopainen Therapeutic differentiation and maturation of lymphatic vessels after lymph node dissection and transplantation Nat Med 13 2007 1458
7. K. Alitalo The lymphatic vasculature in disease Nat Med 17 2011 1371
8. N. Ferrara, H.P. Gerber, and J. LeCouter The biology of VEGF and its receptors Nat Med 9 2003 669
9. M.G. Achen, M. Jeltsch, and E. Kukk Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4) Proc Natl Acad Sci U S A 95 1998 548
10. V. Joukov, T. Sorsa, and V. Kumar Proteolytic processing regulates receptor specificity and activity of VEGF-C EMBO J 16 1997 3898
11. M. Jeltsch, A. Kaipainen, and V. Joukov Hyperplasia of lymphatic vessels in VEGF-C transgenic mice Science 276 1997 1423
12. A. Saaristo, T. Veikkola, and T. Tammela Lymphangiogenic gene therapy with minimal blood vascular side effects J Exp Med 196 2002 719
13. A. Szuba, M. Skobe, and M.J. Karkkainen Therapeutic lymphangiogenesis with human recombinant VEGF-C FASEB J 16 2002 1985
14. S. Hirakawa, and M. Detmar New insights into the biology and pathology of the cutaneous lymphatic system J Dermatol Sci 35 2004 1
15. A. Saaristo, T. Tammela, and J. Timonen Vascular endothelial growth factor-C gene therapy restores lymphatic flow across incision wounds FASEB J 18 2004 1707
16. M.J. Karkkainen, A. Saaristo, and L. Jussila A model for gene therapy of human hereditary lymphedema Proc Natl Acad Sci U S A 98 2001 12677
17. Y.S. Yoon, T. Murayama, and E. Gravereaux VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema J Clin Invest 111 2003 717
18. M. Lahteenvuo, K. Honkonen, and T. Tervala Growth factor therapy and autologous lymph node transfer in lymphedema Circulation 123 2011 613
19. J.A. Rabson, S.J. Geyer, G. Levine, W.M. Swartz, and J.W. Futrell Tumor immunity in rat lymph nodes following transplantation Ann Surg 196 1982 92
20. A.M. Saaristo, T.S. Niemi, T.P. Viitanen, T.V. Tervala, P. Hartiala, and E.A. Suominen Microvascular breast reconstruction and lymph node transfer for postmastectomy lymphedema patients Ann Surg 255 2012 468
21. B. Enholm, T. Karpanen, and M. Jeltsch Adenoviral expression of vascular endothelial growth factor-C induces lymphangiogenesis in the skin Circ Res 88 2001 623
22. T.T. Rissanen, J.E. Markkanen, and M. Gruchala VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses Circ Res 92 2003 1098
23. M. Laitinen, I. Zachary, and G. Breier VEGF gene transfer reduces intimal thickening via increased production of nitric oxide in carotid arteries Hum Gene Ther 8 1997 1737
24. A.M. Puumalainen, M. Vapalahti, and R.S. Agrawal Beta-galactosidase gene transfer to human malignant glioma in vivo using replication-deficient retroviruses and adenoviruses Hum Gene Ther 9 1998 1769
25. S. Aschen, G. Farias-Eisner, and D. Cuzzone Lymph node transplantation results in spontaneous lymphatic reconnection and restoration of lymphatic flow Plast Reconstr Surg 133 2014 301
26. K. Vintersten, C. Monetti, and M. Gertsenstein Mouse in red: red fluorescent protein expression in mouse ES cells, embryos, and adult animals Genesis 40 2004 241
27. M.A. Schnell, Y. Zhang, and J. Tazelaar Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectors Mol Ther 3 2001 708
28. R.H. Simon, J.F. Engelhardt, and Y. Yang Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: toxicity study Hum Gene Ther 4 1993 771
29. M. Wirzenius, T. Tammela, and M. Uutela Distinct vascular endothelial growth factor signals for lymphatic vessel enlargement and sprouting J Exp Med 204 2007 1431
30. J. Goldman, J.M. Rutkowski, and J.D. Shields Cooperative and redundant roles of VEGFR-2 and VEGFR-3 signaling in adult lymphangiogenesis FASEB J 21 2007 1003
31. S.J. Kister, E.F. Conklin, and D.V. Habif Autotransplantation of lymph nodes in the dog Surg Forum 16 1965 206
32. H.J. Rothkotter, and R. Pabst Autotransplantation of lymph node fragments. Structure and function of regenerated tissue Scand J Plast Reconstr Surg Hand Surg 24 1990 101
33. S.P. Tilak, and J.M. Howard Regeneration and autotransplantation of lymph nodes Ann Surg 161 1965 441
34. B.F. Shesol, R. Nakashima, A. Alavi, and R.W. Hamilton Successful lymph node transplantation in rats, with restoration of lymphatic function Plast Reconstr Surg 63 1979 817
35. R.E. Mebius, P.R. Streeter, J. Breve, A.M. Duijvestijn, and G. Kraal The influence of afferent lymphatic vessel interruption on vascular addressin expression J Cell Biol 115 1991 85
36. J. Rutanen, T.T. Rissanen, and J.E. Markkanen Adenoviral catheter-mediated intramyocardial gene transfer using the mature form of vascular endothelial growth factor-D induces transmural angiogenesis in porcine heart Circulation 109 2004 1029
37. A. Anisimov, A. Alitalo, and P. Korpisalo Activated forms of VEGF-C and VEGF-D provide improved vascular function in skeletal muscle Circ Res 104 2009 1302
38. T.P. Viitanen, M.T. Maki, M.P. Seppanen, E.A. Suominen, and A.M. Saaristo Donor-site lymphatic function after microvascular lymph node transfer Plast Reconstr Surg 130 2012 1246
39. T. Viitanen, M. Visuri, and P. Hartiala Lymphatic vessel function and lymphatic growth factor secretion after microvascular lymph node transfer in lymphedema patients Plast Reconstr Surg Glob Open 1 2013 1